The Overprovision of Infectious Disease Medicine

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

This paper demonstrates a so far ignored negative externality imposed by the provision of fife prolonging drugs to infected carriers of infectious diseases. Private optimal usage tends to imply socially inefficient over-provision of life enhancing infectious disease medication. (C) 2003 Elsevier Science B.V. All rights reserved.

Original languageEnglish
Pages (from-to)61-66
Number of pages5
JournalEconomics Letters
Volume80
Issue number1
DOIs
Publication statusPublished - Jul 2003

Keywords

  • epidemics
  • externalities
  • drug provision
  • VACCINATION
  • PRIVATE

Cite this